In early 2016, Drs. Brian A. Logue and Randy Jackson started Analytical and Diagnostic Solutions (ADS) to bring the only rapid (≤60 s) blood cyanide exposure diagnostic to market. Our expertise and research efforts in the analysis of cyanide and its biological metabolites has yielded an academic prototype. The main goal of ADS is to raise funds for advanced development of the cyanide exposure diagnostic and obtain FDA approval for market entry, primarily through applying our bioanalytical chemistry skill set to real world problems our clients present to us.